Vaccinia virus mRNAs synthesized in vitro and in vivo, polyadenylated leader sequences synthesized in vitro in the absence of added GTP, CTP, or UTP or in the presence of 20 ,ug of actinomycin D per ml, and high-molecular-weight RNA synthesized in vitro under limiting ATP concentrations were labeled specifically in the cap structure using [a-32P]GTP and vaccinia-soluble enzyme extracts. The complexity of RNase T1-resistant 5'-terminal oligonucleotides was analyzed by two-dimensional polyacrylamide gel electrophoresis. Approximately 190 unique T1-resistant 5'-terminal oligonucleotides were observed from vaccinia virus 8 to 12S RNA synthesized in vitro. A somewhat greater complexity was observed with polyadenylated leader sequences and actinomycin D RNAs where unique T1-resistant oligonucleotides ranged from approximately 210 to 280 5'-terminal fragments. On a composite fingerprint of the above RNAs, more than 300 identifiable unique T1-resistant 5'-terminal oligonucleotides were observed. Significantly, close to 300 T1-resistant fragments were derived from RNA sedimenting faster than 18S on denaturing sucrose gradients. Analysis of vaccinia RNAs synthesized in vivo in the absence of either de novo protein synthesis or DNA replication or in the presence of actinomycin D gave essentially similar proffles of 5'-terminal T1-resistant oligonucleotide fingerprints consisting of approximately 200 fragments. Analysis of the 5'-terminal Tl-resistant oligonucleotides of vaccinia RNAs present after DNA replication showed essentially the same pattern of early T1-fragments albeit in reduced amounts but in addition revealed a complex pattern of Tl-resistant oligonucleotides unique to this class of vaccinia RNA.
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Vaccinia virus is a large cytoplasmic DNA virus with a genome of approximately 1.2 x 108 daltons. The transcriptional strategy of the virus in vivo has been demonstrated to be tightly controlled temporally; hence, three phases of transcription have been identified: (i) an "immediate early" phase, defined as the transcription of the genome in the absence of de novo protein synthesis during which the viral genome is still in a coated form; (ii) an "early" phase of transcription, defined temporally as the expression of the genome in the absence of DNA replication; and (iii) a "late" phase of transcription, which covers the expression of the genome after DNA replication. These stages of temporal regulation of transcription have been quantified, and there is general agreement that early transcriptional complexity involves 50% of the transcribable sequences, whereas 100% of the transcribable sequences is present at late times (3, 25, 28) . Although quantitative but not qualitative differences in protein synthesis can be distinguished between immediate early and early (6), significant discrepancies in RNA sequences present at these two stages of viral replication have been reported (3, 20, 21) .
The presence of an endogenous DNA-dependent RNA polymerase in poxviruses (20, 23) has allowed the study of transcription of vaccinia in vitro. The complexity of the sequences found during in vitro vaccinia transcription is identical to that present at late times in vivo (3, 28) . Calculations based on the informational content of vaccinia have been made from which it is concluded that approximately 150 to 200 polypeptides of average molecular weights can be colinearly coded by the vaccinia genome (3, 28) .
The in vitro transcripts of vaccinia virus are RNAs of approximately 1,000 bases and contain polyadenylate sequences at the 3' end and are NOTES capped and methylated at the 5' end. In addition, two other types of RNAs have been detected in vitro. One type consists of small RNAs ranging in size from 20 to several hundred bases and include the leading sequence of the transcript. They are capped and methylated at the 5' end and polyadenylated at the 3' end (polyadenylated leader sequences [PALS] ). These RNAs have been synthesized in vitro in reactions where the addition of UTP, CTP, or GTP is omitted from the RNA polymerase reaction, or in the presence of actinomycin D, or from virus treated with UV light (14, 31) . The simplest explanation for the existence of these RNAs is that they are abortive transcription products, but that they may be involved in mRNA maturation has also been considered (31) .
The other type of in vitro transcription product is a high-molecular-weight (HMW) RNA, which is detected in in vitro reactions containing either suboptimal concentrations of ATP or heat-treated virus (18, 26) . Whether this HMW RNA represents a precursor to mature vaccinia mRNA or arises because of dysfunctional termination of the transcript under the perturbing conditions of synthesis is not clear.
Because of the transcriptional complexity present in this system, studies involving these RNAs as populations give little information in understanding the various relationships between them or the regulation of their transcription. In an attempt to decrease this complexity, we elected to study these RNAs by concentrating on the 5' ends. The unique structures of the 5' end of vaccinia RNA, mGpppGm--and mGpppAm-- (35) , and the presence of the pertinent enzymatic functions for generating these structures in crude soluble extracts of vaccinia cores (9) , allow a very sensitive and specific labeling of the 5' ends of these RNAs (22 Figure 1A shows the radioautographic profile of such a composite digestion, whereas a tracing of the T1 spots is shown in Figure 1B . Over 300 definable T1 spots are observed from such a composite gel, indicating both the high resolution of this system and the complexity of the 5' ends of vaccinia transcripts derived in vitro.
In vitro, under conditions of reduced ATP concentrations during RNA synthesis, vaccinia virus synthesizes HMW RNA. This HMW RNA has been partially characterized (4, 14, 24, (26) (27) (28) 30) . It is approximately four to five times larger than the mature vaccinia mRNA that is released from the viral cores. The HMW RNA is capped and methylated at the 5' end, but is not significantly polyadenylated (27) . The HMW RNA can be cleaved while still virion-associated in the presence of ATP and released from the virus or cleaved by an endoribonuclease activity present in soluble extracts of vaccinia cores (13, 27, 29) . The in vitro translation products of the HMW RNA are similar to the polypeptides synthesized in in vitro translation systems programmed with mature monocistronic-sized mRNA, and the translated regions of the HMW RNA are thought to be at or near the 5' end of the RNA (4 027%) and N,N,N' ,N'-tetramethylethylenediamine (0.06%) were added, and the gel was allowed to polymerize while immersed in a water tank. Electrophoresis was performed at room temperature with 0.05 M Tris-borate (pH 8.2) at 600 V for approximately 18 h until the bromophenol blue dye marker had migrated 24 cm from the center of the firstdimension gel strip. Autoradiography of the wet gels was performed at -70°C by using Kodak XR-2 film and Dupont Cronex intensifying screens.
vaccinia-associated endoribonuclease activity that cleaves HMW RNA (29) and a 5'-polynucleotide kinase activity capable of modifying termini internally derived from the cleavage of HMW RNA for subsequent capping reactions (32) must still be considered.
It is interesting to note that the PALS and HMW RNA contain a greater complexity of 5'-terminal Tl-resistant oligonucleotides than the in vitro 8 to 12S RNA. Since both PALS and HMW RNA are derived from reactions where the concentration of at least one triphosphate is limiting, the number of 5' ends may represent heterogeneity of initiation of the RNA transcript under these nonoptimal conditions. Heterogeneity at the 5' ends of mRNAs has been detected in vivo for other animal viruses such as adenovirus, simian virus 40, and polyoma (1, 5, 10, 11, 15, 17 (27, 30) . RNA sedimenting faster than HeLa 18S ribosomal RNA was recovered from the dimethylsulfoxide-sucrose gradients, labeled specifically in the 5'-terminal cap structure, and digested with RNase T1 as described in Fig. 1. A 3- To understand the temporal regulation of vaccinia transcription in vivo, the T1-resistant 5'-terminal oligonucleotides derived from in vivo vaccinia RNA were analyzed and compared with the fingerprint obtained with in vitro RNA (Fig. 3A) .
When the T1-resistant 5'-terminal oligonucleotides derived from immediate early vaccinia RNA (Fig. 3B) were compared with those derived from early transcripts (Fig. 3C) , essentially similar fingerprints were obtained, although some unique T1 fragments peculiar to each temporal class of RNA were detected. The similarity in the fingerprints of these two classes of vaccinia RNA is not indicative of major differences in sequence complexity, consistent with the data reported by Boone and Moss (3) .
Analysis of the T1-resistant 5'-terminal oligonucleotides derived from late vaccinia transcription is shown in Fig. 3D The reason for the lack of resolution of these apparently large 5'-terminal oligonucleotides derived from RNA synthesized in the absence of metabolic inhibitors is not known, but the possible charge heterogeneity in the capped moieties of the RNAs may be a contributing factor (2).
removed, and the aqueous phase reextracted until the interphase was clear. Two additional extractions with chloroform were performed, and the aqueous phase dialyzed extensively against 10 mM Tris-hydrochloride (pH 7.4) containing 0.1 mM Na3EDTA at 4°C. DNA was concentrated to approximately 100 pg/ml with Ficoll.
Aminobenzyloxymethyl paper was obtained from Schleicher and Schuell and converted to the diazotized form by the specifications of the manufacturer. Vaccinia DNA was transferred to diazobenzyloxymethyl (DBM) paper as follows. Purified DNA (1.7 mg) in 25 ml was randomly cleaved by sonication, mixed with an equal volume of 2% agarose, poured into a block (8 by 14 by 0.4 cm) and allowed to solidify. The DNA-containing agarose was then treated successively with 0.25 M HCI, 0.5 M NaOH, and 1 M sodium acetate buffer (pH 4.0), and transferred to a sheet of DBM paper (8 by 14 cm) essentially as described by Wahl et al. (34) . The DBM paper was cut into strips (2 by 14 cm) and prehybridized for 6 h at 42°C in 50% formamide, Sx SSC (0.15 M NaCl and 0.015 M sodium-citrate), Sx Denhardt reagent (0.02% bovine serum albumin, 0.02% polyvinyl pyrrolidone, and 0.02% Ficoll) (7) ; 1% glycine; and 500 p.g of sonicated, denatured salmon sperm DNA in 50 mM sodiumphosphate buffer (pH 6.5). Polyadenylate RNA (200 to 500 jg) isolated from vaccinia-infected HeLa cells was dissolved in 3 ml of hybridization buffer (50% formamide, 5x SSC, 1x Denhardt, 0.1 mM Na3EDTA, 0.2% sodium dodecyl sulfate, 100 pLg sonicated, denatured salmon sperm DNA, and 10%o dextran sulfate in 20 mM sodium-phosphate buffer [pH 6.5]) (34), heated for 65°C for 30 min, then hybridized to the DBM paper in a siliconized glass vial at 42°C for 20 h. The DBM paper was washed five times with 40 ml of 2x SSC and 0.2% sodium dodecyl sulfate at room temperature for 15 min per wash, three times with 0.2x SSC, and 0.2% at 600C for 30 min per wash, and finally two times in 10 ml of 2 mM Na3EDTA (pH 8.0). The RNA was eluted from the DNA by boiling the DBM paper in 3 ml of deionized, redistilled, autoclaved water for 3 min followed by rapid quenching in a dry ice-methanol bath. Sodium-acetate (pH 5.5) was added to 0.2 M and the RNA recovered by ethanol precipitation. In control experiments, a second round of hybridization selection of radiolabeled RNA gave an identical T1 fingerprint suggesting no significant levels of host RNA contamination. In vivo RNAs were first treated with sodium-periodate and analine to remove the endogenous blocking guanosine residue as described (12) before labeling in reactions identical to those used for in vitro RNAs described in the legend to Fig.  1 (36) and are also being pursued in our laboratory.
